| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |